Related Experiment Videos
[Clinicopathological study on reported case for bronchogenic carcinoma]
S Tanimura1, K Sakaguchi, H Tomoyasu
1Department of Thoracic Surgery, Toranomon Hospital, Tokyo, Japan.
Kyobu Geka. the Japanese Journal of Thoracic Surgery
|January 1, 1995
Summary
Reoperation for bronchogenic carcinoma recurrence is uncommon (3.2%) but necessary for selected patients. Early detection and surgical intervention can improve survival outcomes for lung cancer patients.
Area of Science:
- Thoracic Surgery
- Surgical Oncology
- Pulmonary Medicine
Background:
- Bronchogenic carcinoma (lung cancer) management often involves surgical resection.
- Recurrence or metastasis can occur after initial treatment, necessitating further intervention.
Observation:
- Eight of 253 patients (3.2%) with lung cancer required reoperation for local recurrence or intrathoracic metastasis.
- All cases involved well or moderately differentiated adenocarcinoma.
- The average interval between surgeries was 34 months.
Findings:
- Reoperation strategies included completion pneumonectomy, wedge resection, segmental resection, and lymph node excision.
- Metastatic patterns included local recurrence, ipsilateral and contralateral lung metastases, and mediastinal lymph node metastasis.
- Post-reoperation survival varied, with four patients dying from distant metastases, two from pneumonia, and two remaining alive.
Implications:
- Reoperation for recurrent or metastatic lung cancer is a viable option in select cases.
- Histological type (adenocarcinoma) and pattern of recurrence influence treatment decisions.
- Further research is needed to optimize patient selection and surgical techniques for improved long-term outcomes.